One of the main causes of death beyond the first year after heart transplantation is cardiac allograft vasculopathy (CAV). This review summarises the current understanding of its complex pathophysiology, detection and treatment, including the available data on non-invasive imaging modalities used for screening and diagnosis. A better understanding of this entity is crucial to improving the long-term outcomes of the growing population of patients with a heart transplant.
- heart transplantation
- cardiac imaging techniques
- positron-emission tomography
- magnetic resonance imaging
Statistics from Altmetric.com
Contributors JMOL wrote the following sections: abstract, introduction, pathophysiology, definition and epidemiology, treatment, revascularisation and retransplant. PB wrote the following sections: clinical manifestations, diagnosis and prognostic markers, non-invasive evaluation of cardiac allograft vasculopathy, dobutamine stress echocardiography, myocardial perfusion imaging with nuclear techniques, CTA, cMRI and summary.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
Provenance and peer review Commissioned; externally peer reviewed.
Author note Additional references can be found in online supplemental file 1.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.